
ICMR will choose 20 healthcare facilities, largely government-run hospitals, across India to begin clinical trials for convalescent plasma transfusion therapy, a treatment that is being explored for critically-ill Covid-19 patients.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XXXyzy
via
IFTTT
0 comments:
Post a Comment